NAT14 anticorps (N-Term)
Aperçu rapide pour NAT14 anticorps (N-Term) (ABIN953608)
Antigène
Voir toutes NAT14 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 12-41, N-Term
-
Specificité
- This antibody recognizes Human and Mouse NAT14 (N-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 12-41 amino acids from the N-terminal region of Human NAT14.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- NAT14 (N-Acetyltransferase 14 (GCN5-Related, Putative) (NAT14))
-
Autre désignation
- NAT14
-
Sujet
- Synonyms: EC 2.3.1, K562 cell-derived leucine-zipper-like protein 1, KLP1, N-acetyltransferase 14, NAT14
-
Poids moléculaire
- 21650 Da
-
ID gène
- 57106
-
NCBI Accession
- NP_065111
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-